These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7428402)

  • 21. The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia.
    Hagstadius S; Gustafson L; Risberg J
    Psychopharmacology (Berl); 1984; 83(4):321-6. PubMed ID: 6436861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the vincamine-papaverine association. VI. Interference with alpha receptors. Preliminary clinical evidence.
    Pedini G; Costa G; Bossi M; Manani G
    Agressologie; 1979; 20(4):221-3. PubMed ID: 233544
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response relationship of vindeburnol based on spectral analysis of posturographic recordings.
    Patat A; Le Go A; Foulhoux P
    Eur J Clin Pharmacol; 1985; 29(4):455-9. PubMed ID: 3912189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of clonidine and yohimbine on sleep in man: polygraphic study and EEG analysis by normalized slope descriptors.
    Kanno O; Clarenbach P
    Electroencephalogr Clin Neurophysiol; 1985 Jun; 60(6):478-84. PubMed ID: 2408846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of a vincamine-papaverine combination on platelet aggregation in geriatric patients with glucose and/or lipid metabolism disorders].
    Petruzzi E; Bucalossi A; Chiostri R
    Minerva Cardioangiol; 1985 Sep; 33(9):561-4. PubMed ID: 4088484
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the vincamine-papaverine association. V. Interference with alpha receptors. Experimental study.
    Costrini R; Nunziata A; Galloro P; Cattani L
    Agressologie; 1979; 20(4):217-20. PubMed ID: 233543
    [No Abstract]   [Full Text] [Related]  

  • 29. Vincamine TPS activity on glycoconjugate metabolism of the brain: effect on lysosomal enzymes.
    Federico A; D'Amore I
    Int J Clin Pharmacol Res; 1984; 4(4):277-9. PubMed ID: 6500774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vincamine: a psychogeriatric agent blocking synaptic potentiation in hippocampus.
    Olpe HR; Barrionuevo G; Lynch G
    Life Sci; 1982 Nov; 31(18):1947-53. PubMed ID: 7176804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [32P-incorporation in adenosine phosphates of the rat brain after oral application of vincamine for 2 weeks (author's transl)].
    Kanig K; Hoffmann KH
    Arzneimittelforschung; 1979; 29(1):33-4. PubMed ID: 582115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulatory effect of several cerebral circulatory drugs in man, with special reference to aminophylline, papaverine, cyclandelate, vincamine, prostaglandin E1 and isoxsuprine.
    Miyazaki M
    Jpn Circ J; 1978 Apr; 42(4):433-40. PubMed ID: 702768
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the vincamine-papaverine association. IV. Interference with beta-receptors in experimental animals.
    Cattani L; Costrini R; Manani G; Galzigna L; Giron GP; Costa G; Civran E; Bossi M
    Agressologie; 1978; 19(6):385-91. PubMed ID: 35999
    [No Abstract]   [Full Text] [Related]  

  • 35. Trachealis responses induced by vincamine and vinpocetine; inhibition by indomethacin and Ca2+ dependence.
    Machová J; Bauer V; Bilcíková L
    Eur J Pharmacol; 1989 Mar; 162(3):387-95. PubMed ID: 2744076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of vincamine on blood viscosity].
    Ehrly AM; Landgraf H
    Fortschr Med; 1982 May; 100(20):969-71. PubMed ID: 7095712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of spectrum analysis of equilibration recordings (posturography) in clinical pharmacology of vindeburnol].
    Patat A; Foulhoux P; Venet R; Memin Y
    Therapie; 1984; 39(6):639-45. PubMed ID: 6531737
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease.
    Martucci N; Manna V; Agnoli A
    Int J Clin Pharmacol Res; 1984; 4(4):291-302. PubMed ID: 6500776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid communication the activating activity of vincamine, piracetam, and hydergine on the activity of the noradrenergic neurons of the locus coeruleus.
    Olpe HR; Steinmann MW
    Behav Neural Biol; 1981 Oct; 33(2):249-51. PubMed ID: 7305817
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of vincamine on some enzymatic activities from various areas of the beagle dog cerebral cortex.
    Benzi G; Arrigoni E; Pastoris O; Marzatico F; Curti D; Piacenza G; Villa RF
    Farmaco Sci; 1981 Sep; 36(9):811-6. PubMed ID: 7297673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.